U.S. FDA

Evolution step-up growth trajectory upward trajectory
Pharma

How biosimilar developers are embracing next phase of US market

Although the so-called biosimilar ‘void’ could pose challenges to upcoming biosimilar availability, the opportunity it presents is also immense.
Sanofi

Sanofi unit in Ireland dinged by FDA on Altuviiio production

Jul 1, 2026 2:52pm
FDA stop sign

FDA snubs Sobi’s gout drug over manufacturing issues

Jun 29, 2026 11:04am
Layoffs

ADC plots 17% staff cuts amid Zynlonta safety concerns

Jun 24, 2026 10:19am
Pharma money pharma money pharma profits Big Pharma sales drug sales

Obesity meds, China drive $2T in projected 2032 drug sales: report

Jun 23, 2026 9:00am
cell therapy oncology cancer CAR-T cells

Cellares, Ori dominate automated cell therapy production: report

Jun 18, 2026 10:10am